Acremonium nail bed mycetoma masquerading as subungual squamous cell carcinoma

Kyriakou, Georgia; Gialeli, Efthymia; Lekkou, Alexandra; Vryzaki, Eleftheria; Ravazoula, Panagiota; Georgiou, Sophia

doi:10.5070/d3261047191

Search citation statements

Order By: Relevance

Paper Sections

Select...

Geographic Distribution1

In Vitro Activity1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2021

2022

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(2 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This case highlights an unusual localization (subungual) of eumycetoma which should be considered in the differential diagnosis of nail lesions. In another case reported by Kyriakou et al 8 in 2020, subungual mycetoma, caused by Acremonium spp. was successfully treated with intravenous liposomal amphotericin B (4 mg/kg/d) for 10 days followed by surgical debridement and oral voriconazole (200 mg b.d.)…”

Section: Geographic Distributionmentioning

confidence: 89%

A rare subungual eumycetoma in a cancer survivor: A case report

Maximov

Kochergin

Ditmarova

et al. 2022

Acad Dermatol Venereol

View full text Add to dashboard Cite

Section: Geographic Distributionmentioning

confidence: 89%

A rare subungual eumycetoma in a cancer survivor: A case report

Maximov

Kochergin

Ditmarova

et al. 2022

Acad Dermatol Venereol

View full text Add to dashboard Cite

“…Furthermore, olorofim has showed activity against some uncommon eumycetoma causative agents such as Microascus and Scopulariopsis species [50]. These species have displayed a reduced susceptibility to the azoles antifungal; additionally, the drug was promising for the treatment of Acremonium species, Paecilomyces variotii, with a high MIC for voriconazole [51][52][53].…”

Section: In Vitro Activitymentioning

confidence: 99%

Eumycetoma Medical Treatment: Past, Current Practice, Latest Advances and Perspectives

Siddig

Ahmed

Ali

et al. 2021

Microbiology Research

View full text Add to dashboard Cite

Mycetoma is a neglected tropical disease that is associated with poor communities and socioeconomically impaired individuals in the tropical and sub-tropical areas. Interestingly, the disease is caused by either bacteria (actinomycetoma) or fungus (eumycetoma). The latter form of the disease, eumycetoma, is the most common type in Africa. Eumycetoma is characterized by a prolonged disease duration and low cure rate. The effective case management of eumycetoma largely depends on the accurate diagnosis and identification of the causative agent to the species level and evaluating its susceptibility to the available drugs. This review summarizes the currently available and used antifungal agents for the treatment of eumycetoma and discusses optimizing the newly developed antifungals as a potential second line for eumycetoma treatment.

show abstract

Acremonium nail bed mycetoma masquerading as subungual squamous cell carcinoma

Cited by 2 publications

References 6 publications

A rare subungual eumycetoma in a cancer survivor: A case report

A rare subungual eumycetoma in a cancer survivor: A case report

Eumycetoma Medical Treatment: Past, Current Practice, Latest Advances and Perspectives

Contact Info

Product

Resources

About